Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)Eunae Sandra Cho, Levon M. Khachigian, Fergal J. Moloney et al.|The Lancet|2013Cited by 107
TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone.Frank Martiniuk, William R. Levis, Kam-Meng Tchou-Wong et al.|PubMed|2010Cited by 23